Search results
Results from the WOW.Com Content Network
India: Cause: COVID-19 pandemic in India: Target: Immunisation of Indians against COVID-19: Budget ₹ 35,000 crore (US$4.0 billion) [1] Organised by: Government of India Indian Council of Medical Research State governments of India: Participants: 1,025,789,302 people with one dose administered of Covaxin or Oxford–AstraZeneca vaccine or ...
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [ 8 ] and Canada, [ 9 ] and the European Union [ 5 ] to treat systemic lupus erythematosus and lupus nephritis.
Boxes of AstraZeneca's COVID-19 vaccine from India are delivered in Brazil (January 2021). Coordination of international air cargo is an essential component of time- and temperature-sensitive distribution of COVID‑19 vaccines, but, as of September 2020, the air freight network is not prepared for multinational deployment.
The first cases of COVID-19 in India were reported on 30 January 2020 in three towns of Kerala, among three Indian medical students who had returned from Wuhan, the epicenter of the pandemic. [10] [11] [12] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March. Infection rates started to drop in September. [13]
The National Centre for Disease Informatics and Research, ICMR, released a document titled "Guidance for appropriate recording of COVID-19 related deaths in India". [2] In March 2020, the first two COVID-19 infected people to die in India officially died due to their co-morbidities and not COVID-19. [3]
The following is the timeline of the COVID-19 pandemic in India from January 2021 to the May 2021. The complexity of the COVID-19 data reporting in India has been scrutinized extensively because of the disagreement between the undocumented morbidity rate and the low rates of case fatality in comparison to other countries.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us